The objective of this Fund is to achieve income and capital growth through investment primarily in a range of equity and equity-related securities.
Name | % Net Assets |
---|---|
ConocoPhillips | 2.7% |
British American Tobacco plc | 2.5% |
Nestle | 2.5% |
Centrica plc | 2.2% |
AstraZeneca plc | 2.1% |
Du Pont | 2.1% |
Pepsico Inc | 2.1% |
Vodafone Group plc | 2.1% |
Philip Morris International | 2.1% |
Allianz | 2.0% |
Key | % Net Assets |
---|---|
ConocoPhillips | 2.7% |
British American Tobacco plc | 2.5% |
Nestle | 2.5% |
Centrica plc | 2.2% |
Other | 90.1% |
Date | 10-May-2021 |
---|---|
NAV | 242.30p |
Currency | GBP |
Change | 0.000p |
% | n/a |
YTD change | 242.30p |
YTD % | n/a |
Fund Inception | 23/05/2008 |
---|---|
Fund Manager | n/a |
TER | 1.77 (28-Feb-2013) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research